ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma

The aim of this observational study was to test whether ABO blood type was a prognostic factor for pancreatic ductal adenocarcinoma (PDAC) patients and whether other risk factors could influence pancreatic cancer patients’ survival. This study included 610 patients who were diagnosed as pancreatic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuang-Shuang, Zhou, Cong-Ya, Liao, Rong, Xiong, Lai, Weng, Ning-Na, Zhao, Ya-Qin, Mason, Clifford, Gou, Hong-Feng, Yi, Cheng, Zhu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220786/
https://www.ncbi.nlm.nih.gov/pubmed/32243360
http://dx.doi.org/10.1097/MD.0000000000019413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220786/
https://www.ncbi.nlm.nih.gov/pubmed/32243360
http://dx.doi.org/10.1097/MD.0000000000019413

Ejemplares similares